Peptides surge in popularity for anti-aging, but a dark gray market poses serious risks. Experts call for oversight. GLP-1 agonists like semaglutide spark a peptide revolution, but unapproved compound...
Exploring the unregulated parallel research ecosystem around BPC-157, its potential benefits, and the ethical dilemmas it presents. The rise of BPC-157 in biohacker communities highlights both its the...